Oral Treatment of Central Serous Chorioretinopathy Patients Using Propranolol Tablets

Purpose: To evaluate the pharmacological effects of propranolol treatment of patients with central serous chorioretinopathy (CSCR) over 4 months. Results: Among the 89 male and 31 female patients, the mean BCVA decreased to 0.42 ± 0.08 logMAR during CSCR attacks. Oral propranolol showed good effecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Li-Chai, Ma, Jui-Wen, Shieh, Po-Chuen, Horng, Chi-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690838/
https://www.ncbi.nlm.nih.gov/pubmed/33114121
http://dx.doi.org/10.3390/ph13110336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690838/
https://www.ncbi.nlm.nih.gov/pubmed/33114121
http://dx.doi.org/10.3390/ph13110336

Ejemplares similares